Abstract

This IAA will assess the expression and biological activity among the twelve subtypes of IFN-alpha and three subtypes of IFN-lambda with the goal of showing that expression patterns of IFN-alpha and IFN-lambda will serve as a rapid marker for protective vaccination against Ebola and other filovirus infections.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
NIH Inter-Agency Agreements (Y01)
Project #
AAI12033001-1-0-1
Application #
8542470
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2012
Total Cost
$100,000
Indirect Cost

  Institution

Name
National Institute of Allergy and Infectious Diseases
Department
Type
DUNS #
City
State
Country
Zip Code